Nat Simons Thermo Fisher Scientific Inc. Transaction History

Meritage Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$255.3 - $340.05 $210 Million - $279 Million	-821,795 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$271.93 - $328.04 $24 Million - $28.9 Million	-88,162 Reduced 9.69%	821,795 $267 Million
Q3 2019 Nov 14, 2019	BUY	$268.46 - $305.43 $50.9 Million - $57.9 Million	189,478 Added 26.3%	909,957 $265 Million
Q1 2019 May 13, 2019	BUY	$212.17 - $273.72 $498,811 - $643,515	2,351 Added 0.33%	720,479 $197 Million
Q4 2018 Feb 13, 2019	SELL	$208.47 - $251.98 $34.8 Million - $42 Million	-166,868 Reduced 18.86%	718,128 $161 Million
Q3 2018 Nov 13, 2018	SELL	$205.57 - $244.32 $16.1 Million - $19.2 Million	-78,433 Reduced 8.14%	884,996 $216 Million
Q2 2018 Aug 13, 2018	SELL	$203.14 - $219.53 $19.4 Million - $21 Million	-95,556 Reduced 9.02%	963,429 $200 Million
Q1 2018 May 14, 2018	SELL	$192.98 - $224.11 $3.28 Million - $3.81 Million	-16,990 Reduced 1.58%	1,058,985 $219 Million
Q4 2017 Feb 14, 2018	BUY	$182.03 - $200.37 $2.11 Million - $2.32 Million	11,581 Added 1.09%	1,075,975 $204 Million
Q3 2017 Nov 13, 2017	BUY	$171.74 - $194.04 $183 Million - $207 Million	1,064,394	1,064,394 $201 Million

2,832

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

Stay updated on Meritage Group LP and Nat Simons with notifications on news.